Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound

Urology

Volumn 49, Issue 4, 1997, Pages 548-557

  Roehrborn, Claus G ^a   Girman, Cynthia J ^a   Rhodes, Thomas ^a   Hanson, Karen A ^a   Collins, Gerald N ^a   Sech, Scott M ^a   Jacobsen, Steven J ^a   Garraway, W Michael ^a   Lieber, Michael M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TUMOR VOLUME; ULTRASOUND;

AGED; HUMANS; MALE; MIDDLE AGED; PALPATION; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC HYPERPLASIA; RECTUM;

EID: 0030971166     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00031-9     Document Type: Article

References (29)

1. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 17:1990;241-246.
2. Barry MJ, Cockett AT, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol. 150:1993;351-358.
3. Cockett ATK, Aso Y, Denis L, Murphy G, Khoury S, Abrams P, Barry M, Carlton GE, Fitzpatrick J, Gibbons R, et al. Recommendations of the International Consensus Committe. Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G. The 3rd International Consultation on Benign Prostatic Hyperplasia. 1996;Scientific Communication International Ltd, Jersey, Channel Islands.
4. Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Chute CG, Panser LA, Lieber MM. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol. 153:1995;1510-1515.
5. Lepor H. Alpha-adrenergic antagonists for the treatment of symptomatic BPH (review). Int J Clin Pharmacol. 27:1989;151-155.
6. Lepor H, Shapiro E. This month in investigative urology: alpha-adrenergic innervation of the prostate: insights into pharmacotherapy of BPH. J Urol. 143:1990;590-591.
7. Lepor H. Alpha-blockade for the treatment of benign prostatic hyperplasia (review). Urol Clin North Am. 22:1995;375-386.
8. Lepor H, Henry D, Laddu AR. The efficacy and safety of terazosin for the treatment of symptomatic BPH. Prostate. 18:1991;345-355.
9. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med. 327:1992;1185-1191.
10. Boyle P, Gould AL, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials. Urology. 48:1996;398-405.
11. Meyhoff HH, Hald T. Are doctors able to assess prostatic size? Scand J Urol Nephrol. 12:1978;219-221.
12. Meyhoff HH, Ingemann L, Nordling J, Hald T. Accuracy in preoperative estimation of prostatic size. A comparative evaluation of rectal palpation, intravenous pyelography, urethral closure pressure profile recording and cystourethroscopy. Scand J Urol Nephrol. 15:1981;45-51.
13. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 270:1993;860-864.
14. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, Lieber MM. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 150:1993;85-89.
15. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 338:1991;469-471.
16. Collins GN, Lee RJ, Russell EB, Raab GM, Hehir M. Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia. Br J Urol. 71:1993;451-456.
17. Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ. The efficacy of terazin, finesteride, or both in benign prostatic hyperplasia. N Engl J Med. 335:1996;533-539.
18. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol. 145:1991;984-987.
19. Varenhorst E, Berglund K, Löfland O, Pedersen K. Inter-observer variation in assessment of the prostate by digital rectal examination. Br J Urol. 72:1993;173-176.
20. Bissada NK, Finkbeiner AE, Redman JF. Accuracy of preoperative estimation of resection weight in transurethral prostatectomy. J Urol. 116:1976;201-202.
21. Roehrborn CG, Chinn HK, Fulgham PF, Simpkins KL, Peters PC. The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. J Urol. 135:1986;1190-1193.
22. McConnell JD, Barry MJ, Bruskewitz RC, Bueschen AJ, Denton SE, Holtgrewe HL, Lange JL, McClennan BL, Mebust WK, Reilly NJ, et al. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline. February 1994;Agency for Health Care Policy and Research, Rockville, Md. Public Health Service, US Department of Health and Human Services.
23. Watanabe H, Igari D, Tanahashi Y, Harada K, Saito M. Measurements of size and weight of prostate by means of transrectal ultrasonotomography. Tohoku J Exp Med. 114:1974;277-285.
24. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology. 179:1991;49-53.
25. Collins GN, Raab GM, Hehir M, King B, Garraway WM. Observer variability and reproducibility of transrectal ultrasound in the measurement of prostate volume. Ultrasound Med Biol. 21:1995;1101-1105.
26. Bates TS, Reynard JM, Peters TJ, Gingell JC. Determination of prostatic volume with transrectal ultrasound: a study of intra-observer and interobserver variation. J Urol. 155:1996;1299-1300.
27. Barry MJ, Girman CJ, O'Leary MP, Walker-Corkery ES, Binkowitz BS, Cockett ATK, Guess HA. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. J Urol. 153:1995;99-103.
28. Rhodes T, Girman CJ, Jacobsen SJ, Guess HA, Oesterling JE, Lieber MM. High variability change in prostate volume by transrectal ultrasound over time in untreated men. (abstract) J Urol. 155:1996;461A.
29. Rahmouni A, Yang A, Tempany CM, Frenkel T, Epstein J, Walsh P, Leichner PK, Ricci C, Zerhouni E. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr. 16:1992;935-940.